Uniqure announces alignment with fda on key elements of accelerated approval pathway for amt-130 in huntington's disease

~ u.s. food and drug administration (fda) agrees that data from ongoing phase i/ii studies compared to a natural history external control may serve as the primary basis for a biologics license application (bla) for accelerated approval ~
AMT Ratings Summary
AMT Quant Ranking